Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study)

Human Psychopharmacology

Volumn 28, Issue 1, 2013, Pages 1-6

  Miljević, Čedo ^a   Nikolić Kokić, Aleksandra ^a   Nikolić, Milan ^b   Niketić, Vesna ^b   Spasić, Mihajlo B ^a   Lečić Toševski, Dušica ^a   Blagojević, Duško ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

anti oxidant defence enzymes; atypical antipsychotics; oxidative stress

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CATALASE; CLOZAPINE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; OLANZAPINE; QUETIAPINE; SERTINDOLE; ZIPRASIDONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; HEMOLYSIS; HUMAN; IN VITRO STUDY; INCUBATION TEMPERATURE; MALE; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

ADULT; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CATALASE; CLOZAPINE; DIBENZOTHIAZEPINES; ENZYME ACTIVATION; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; IMIDAZOLES; INDOLES; MALE; PIPERAZINES; QUINOLONES; SULPIRIDE; SUPEROXIDE DISMUTASE; THIAZOLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873869323     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2272     Document Type: Article

References (44)

1. Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ,. 1986. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 32 (5): 805-807.
2. Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F,. 2000. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med 38 (12): 1277-1281.
3. Beauchamp C, Fridovich I,. 1971. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44 (1): 276-287.
4. Ben Othmen L, Mechri A, Fendri C, et al,. 2008. Altered antioxidant defence system in clinically stable patients with schizophrenia and their unaffected siblings. Prog Neuropsychopharmacology Biol Psychiatry 32 (1): 155-159.
5. Beutler E,. 1982. Catalase: a Manual of biochemical methods. In Red Cell Metabolism, Beutler E, (ed.). Grune and Stratton: New York; 105-106.
6. Bitanihirwe BK, Woo TU,. 2011. Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35 (3): 878-893.
7. Cadet JL, Lohr JB,. 1987. Free radicals and the developmental pathobiology of schizophrenic burnout. Integrative Psychiatry 5 (1): 40-43.
8. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M,. 2009. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19 (2): 220-30.
9. Drabkin DL, Austin JH,. 1935. Spectrophotometric studies. II Preparations from washed blood cells: nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 112: 51-55.
10. Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP,. 2003. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids 69 (6): 393-399.
11. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L,. 2006. Oxidative stress involvement in schizophrenia pathophysiology: a review. Encéphale 32 (2 Pt 1): 244-252.
12. Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmonte-de-Abreu P,. 2006. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 30 (3): 512-515.
13. Glatzle D, Vuilleumier JP, Weber F, Decker, K,. 1974. Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans. Experientia 30 (6): 665-667.
14. Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O,. 2001. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 6 (1): 66-73.
15. Hinkle ED, Wiersma W, Jurs GS,. 1994. In Applied Statistics for Behavioural Sciences. Houghton Mifflin Company: Boston; 574.
16. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M,. 2003. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 60 (6): 585-594.
17. Horrobin DF,. 1999. Lipid metabolism, human evolution and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 60 (5-6): 431-437.
18. Jeding I, Evans PJ, Akanmu D, et al,. 1995. Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochem Pharmacol 49 (3): 359-365.
19. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N,. 2002. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20 (2): 171-175.
20. Leammli UK,. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
21. Mahadik SP, Evans DR,. 2003. Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. Psychiatr Clin North Am 26 (1): 85-102.
22. Mahadik SP, Mukherjee S,. 1996. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19 (1): 1-17.
23. Miljević Č, Nikolić-Kokić A, Saičić ZS, et al,. 2010a. Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication. Psychiatry Res 178 (1): 68-72.
24. Miljević C, Nikolić M, Nikolić-Kokić A, et al,. 2010b. Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients. Prog Neuro-Psychopharmacol Biol Psychiatry 34 (2): 303-307.
25. Misra HP, Fridovich I,. 1972. The role of superoxide anion in autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247 (10): 3170-3175.
26. Ng F, Berk M, Dean O, Bush AI,. 2008. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11 (6): 851-876.
27. Nikolić-Kokić A, Blagojević D, Spasić MB,. 2010. Complexity of free radical metabolism in human erythrocytes. Review. J Med Biochem 29 (3): 189-195.
28. Paglia DE, Valentine WN,. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1): 158-169.
29. Parikh V, Khan MM, Mahadik SP,. 2003. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37 (1): 43-51.
30. Pillai A, Parikh V, Terry AV Jr., Mahadik SP,. 2007. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 41 (5): 372-386.
31. Polydoro M, Schröder N, Lima MN, et al,. 2004. Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78 (4): 751-756.
32. Pucci V, Mandrioli R, Ferranti A, Furlanetto S, Augusta Raggi M,. 2003. Quality control of commercial tablets containing the novel antipsychotic quetiapine. J Pharm Biomed Anal 32 (4-5): 1037-1044.
33. Ranjekar PK, Hinge A, Hegde MV, et al,. 2003. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121 (2): 109-122.
34. Reddy R, Sahebarao MP, Mukherjee S, Murthy JN,. 1991. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry 30 (4): 409-412.
35. Silke B, Campbell C, King DJ,. 2002. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 16 (4): 355-360.
36. Stojković T, Radonjić NV, Velimirović M, et al,. 2012. Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain. Prog Neuro-Psychopharmacol Biol Psychiatry 39: 192-199.
37. Tsuchihashi M,. 1923. Zur Kenntnis der Blutkatalase. Biochem Z 140: 65-74.
38. Walss-Bass C, Weintraub ST, Hatch J, Mintz J, Chaudhuri AR,. 2008. Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations. Int J Neuropsychopharmacol 11 (8): 1097-1104.
39. Yao JK, van Kammen DP,. 2004. Membrane phospholipids and cytokine interaction in schizophrenia. Int Rev Neurobiol 59: 297-326.
40. Yao JK, Reddy R, McElhinny LG, van Kammen DP,. 1998. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 32 (6): 385-391.
41. Yao JK, Reddy RD, van Kammen DP,. 1999. Human plasma glutathione peroxidase and symptom severity in schizophrenia. Biol Psychiatry 45 (11): 1512-1515.
42. Załuska M, Gajewska J,. 1995. Agranulocytosis in the course of clozapine treatment. Psychiatr Pol 29 (1): 67-77.
43. Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC,. 2003. The effect of risperidone treatment on superoxide dismutase in schizophrenia. J Clin Psychopharmacol 23 (2): 128-31.
44. Zhang XY, Tan YL, Cao LY, et al,. 2006. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 81 (2-3): 291-300.